Our group has found that dyskerin expression and functions are highly variable in human primary breast carcinomas in the general population: tumors characterized by low dyskerin expression also display reduced TERC levels and rRNA pseudouridylation, while the opposite is found in tumors expressing high dyskerin levels [11]. Here, DKC1 is linked to breast carcinoma.